Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Cabaletta Bio(CABA) the Revenue is 0 (--%), Meet estimate;the EBIT is -44.3 M (-19.28%), Beat estimate;the EPS is -0.39 (+45.07%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITExceed expectations
-0.04B19.28%
-0.05B24.54%
+0.00B5.26%
EPSExceed expectations
-0.3945.07%
-0.443.66%
+0.01001.41%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf